Tokyo, Japan, April 25, 2023 - Xenoma Inc., a Healthcare Technology startup developing sophisticated smart apparel, announced the appointment of two new directors to its Board, Kenta Fujita and Keita Ishikawa, experienced sales, and customer success professionals in the medical field.

Since the launch of the Ambulatory ECG Monitoring service “e-skin ECG” in May 2022, Xenoma is working to expand its business in the medical field. To improve the sales team and build a customer success to further expand and strengthen its business, Xenoma will accelerate its growth by incorporating their knowledge and experience.

About Kenta Fujita

After working at Funai Consulting Incorporated, Fujita participated in the launch of sales organizations at Bizreach, Bengo4.com, Medley, and Cellsource. In 2018, he founded Insight, a sales consulting company that supports sales organization for both startups and large companies. In 2020, he founded Graph, where he builds the sales enablement tool GRAPH and provides sales consultation using it.
At Xenoma, he serves as CMO bringing his experience in sales organizations.

About Keita Ishikawa

Ishikawa worked as an MR at Pfizer Inc. In 2016, he joined Medley and participated in the launch of the online medical system and customer success organization. In 2018, he participated in the founding of an M&A advisory firm and was involved in the establishment of an inside sales organization, becoming a member of the company's board of directors; in 2020, he founded Lyra Inc. to provide consulting support to various companies.
At Xenoma, he serves as CCO(Chief Customer Officer) bringing his experience in customer success in the healthcare industry.

Xenoma is committed to achieving its vision of e-skin makes everyone's life HAPPIER and HEALTHIER.